Clover Biopharmaceuticals Secures Exclusive Deal for AdimFlu-S Distribution in China
China-based Clover Biopharmaceuticals, Ltd (HKG: 2197) has announced an exclusive agreement with Adimmune Corporation for...
Hainan Honz Partners with GPI for Pediatric and Maternity Medicine Expansion
China-based Hainan Honz Pharmaceutical Co., Ltd (SHE: 300086) has entered into a three-year partnership with...
MoleculeMind Raises Over RMB 100 Million for AI Protein Design Platform
MoleculeMind, an artificial intelligence (AI)-empowered protein design platform based in Beijing, has reportedly raised over...
Zhejiang Suspends Generic Nesina Trading Due to IP Disputes
Zhejiang’s Provincial Center for Drug & Medical Device Procurement has issued a notification suspending the...
China’s 2022 Western Medicine Trade Analysis: Growth and Challenges
The China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE)...
Wuhan Binhui’s Oncolytic Virus Therapy Awarded Breakthrough Designation by CDE
The Center for Drug Evaluation (CDE) website indicates that China-based Wuhan Binhui Biotechnology Co., Ltd’s...
CDE Awards Priority Review to Eisai’s Lecanemab for Early Alzheimer’s Disease
The Center for Drug Evaluation (CDE) website indicates that Japan-based Eisai’s (TYO: 4523) lecanemab has...
Chunlizhengda to Acquire Majority Stake in Surgimaster for Medical Power Tools
Beijing Chunlizhengda Medical Instruments Co., Ltd (HKG: 1858, SHA: 688236) is poised to acquire a...
Duoning Biotech Secures Global Rights to Junzhen’s Cell Counter Products
China’s Shanghai Duoning Biotechnology Co., Ltd has entered into a licensing deal with compatriot firm...
Sansure Biotech Partners with Hunan Normal University for Research and Talent Development
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced a strategic partnership with...
Amcor Acquires Shanghai-Based MDK to Expand Asia-Pacific Footprint
Switzerland-based packaging firm Amcor (NYSE: AMCR) has unveiled the signing of a deal to acquire...
CSPC’s NBL-020 Gets NMPA Approval for Clinical Study in Advanced Solid Tumors
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced receiving the go-ahead from the National...
Kelun Pharma’s Generic Jardiance Gains New Indication in China
China-based Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422) has obtained another indication approval in China...
Hangzhou Singclean Stripped of VBP Status for Artificial Lenses
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has revealed that Hangzhou Singclean Medical Products Co., Ltd...
Topgen Biopharm Partners with Fudan University for Breast Cancer Gene Detection
Zhejiang-based tumor precision medicine specialist Topgen Biopharm Co., Ltd has entered into a strategic partnership...
By-Health Partners with Meituan’s Drug Purchase APP for New Retail Expansion
China-based By-Health Co., Ltd. (SHE: 300146) has entered into a strategic partnership with Meituan’s drug...
Kangtai Biological Partners with Pakistani Firm for Pneumonia Vaccine Expansion
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has announced a strategic partnership with...
Shanghai-Based REMD Raises Series A+ Funding for Electroporation Device Expansion
Shanghai-based REMD, a leading manufacturer of irreversible electroporation devices, has reportedly raised over RMB 100...
NMPA Approves Keverprazan for Duodenal Ulcers and Reflux Esophagitis
The National Medical Products Administration (NMPA) has granted approval to Jiangsu Carephar Pharmaceutical Co., Ltd’s...
Organon Reports Q4 and Full-Year 2022 Financials with Revenue Declines
US-based Organon Inc. (NYSE: OGN) has released its Q4 and full-year 2022 financial results. Global...